AR128612A1 - Compuestos antibacterianos zwitterionicos - Google Patents
Compuestos antibacterianos zwitterionicosInfo
- Publication number
- AR128612A1 AR128612A1 ARP230100452A ARP230100452A AR128612A1 AR 128612 A1 AR128612 A1 AR 128612A1 AR P230100452 A ARP230100452 A AR P230100452A AR P230100452 A ARP230100452 A AR P230100452A AR 128612 A1 AR128612 A1 AR 128612A1
- Authority
- AR
- Argentina
- Prior art keywords
- compounds
- prevention
- pharmaceutically acceptable
- compound
- treatment
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP22158739 | 2022-02-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR128612A1 true AR128612A1 (es) | 2024-05-29 |
Family
ID=80461664
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP230100452A AR128612A1 (es) | 2022-02-25 | 2023-02-24 | Compuestos antibacterianos zwitterionicos |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20250179066A1 (https=) |
| EP (1) | EP4482583B1 (https=) |
| JP (1) | JP2025508473A (https=) |
| CN (1) | CN118632842A (https=) |
| AR (1) | AR128612A1 (https=) |
| TW (1) | TW202402748A (https=) |
| WO (1) | WO2023161316A1 (https=) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2016347456B2 (en) | 2015-10-27 | 2018-12-13 | F. Hoffmann-La Roche Ag | Peptide macrocycles against acinetobacter baumannii |
| US11505573B2 (en) | 2018-03-28 | 2022-11-22 | Hoffmann-La Roche Inc. | Peptide macrocycles against Acinetobacter baumannii |
| US11819532B2 (en) | 2018-04-23 | 2023-11-21 | Hoffmann-La Roche Inc. | Peptide macrocycles against Acinetobacter baumannii |
| WO2020182648A1 (en) | 2019-03-08 | 2020-09-17 | F. Hoffmann-La Roche Ag | Novel imidazole-pyrazole derivatives |
| CN114981259B (zh) * | 2020-01-22 | 2024-06-18 | 豪夫迈·罗氏有限公司 | 新型杂环化合物 |
-
2023
- 2023-02-23 JP JP2024550248A patent/JP2025508473A/ja active Pending
- 2023-02-23 WO PCT/EP2023/054499 patent/WO2023161316A1/en not_active Ceased
- 2023-02-23 US US18/840,608 patent/US20250179066A1/en active Pending
- 2023-02-23 EP EP23707330.9A patent/EP4482583B1/en active Active
- 2023-02-23 CN CN202380018177.1A patent/CN118632842A/zh active Pending
- 2023-02-24 TW TW112107104A patent/TW202402748A/zh unknown
- 2023-02-24 AR ARP230100452A patent/AR128612A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2023161316A1 (en) | 2023-08-31 |
| CN118632842A (zh) | 2024-09-10 |
| TW202402748A (zh) | 2024-01-16 |
| US20250179066A1 (en) | 2025-06-05 |
| JP2025508473A (ja) | 2025-03-26 |
| EP4482583A1 (en) | 2025-01-01 |
| EP4482583B1 (en) | 2026-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PY0301561A (es) | Compuestos heterociclicos, inhibidores de beta-lactamasas | |
| Bai et al. | Synthesis and antibacterial bioactivities of cationic deacetyl linezolid amphiphiles | |
| DOP2020000058A (es) | Compuestos monobactámicos cromanos para el tratamiento de infecciones bacterianas | |
| PA8524501A1 (es) | Antibioticos macrolidos | |
| CL2021002263A1 (es) | Compuestos antibacterianos (solicitud divisional 202001147) | |
| CO2019002624A2 (es) | Compuestos antibióticos | |
| EA201391325A1 (ru) | Новые производные цефалоспорина и их фармацевтические композиции | |
| CN101578045A (zh) | 抗微生物组合物 | |
| MX2022007412A (es) | Compuestos novedosos y sus usos. | |
| CA2659391A1 (en) | Antibiotic composition | |
| Padhee et al. | Activity of lipo-cyclic γ-AApeptides against biofilms of Staphylococcus epidermidis and Pseudomonas aeruginosa | |
| CL2023002933A1 (es) | Compuestos de lactivicina, su preparación y uso como agentes antibacterianos | |
| WO2005070945A8 (ja) | メチシリン耐性黄色ブドウ球菌（ｍｒｓａ）に有効な新規アミノグリコシド系抗生物質 | |
| MX2024000036A (es) | Compuestos novedosos y su uso. | |
| AR128612A1 (es) | Compuestos antibacterianos zwitterionicos | |
| JP2024009968A5 (https=) | ||
| PE20190459A1 (es) | Inhibidores de beta-lactamasa | |
| AR126467A1 (es) | Derivados de imidazol y su uso como antibióticos | |
| Abouelhassan et al. | Rapid kill assessment of an N-arylated NH125 analogue against drug-resistant microorganisms | |
| DE602005023492D1 (de) | 2-arylmethylazetidincarbapenemderivate und deren herstellung | |
| AR060494A1 (es) | Compuestos antibacterianos | |
| Strus et al. | Taurine haloamines and biofilm. Part I: antimicrobial activity of taurine bromamine and chlorhexidine against biofilm forming Pseudomonas aeruginosa | |
| CN106794250A (zh) | 包含抗菌剂的药物组合物 | |
| Mataracı‐Kara et al. | Active Quinolinequinones against Methicillin‐Resistant Staphylococcus spp | |
| JP2020529471A (ja) | 微生物のコロニー形成を抑制するための置換トラン |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |